TY - JOUR
T1 - Increasing uptake of evidence-based screening services though a community health worker-delivered multimodality program
T2 - Study protocol for a randomized pragmatic trial
AU - Carrasquillo, Olveen
AU - Seay, Julia
AU - Jhaveri, Vasanti
AU - Long, Timothy
AU - Kenya, Sonjia
AU - Thomas, Emmanuel
AU - Sussman, Daniel
AU - Trevil, Dinah
AU - Koru-Sengul, Tulay
AU - Kobetz, Erin
N1 - Publisher Copyright:
© 2020 The Author(s).
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/4/29
Y1 - 2020/4/29
N2 - Background: Underserved ethnic minority populations experience significant disparities in HIV, hepatitis C virus (HCV), colorectal cancer (CRC), and cervical cancer incidence and mortality. Much of the excess burden of these diseases among underserved communities is due to lack of preventive care, including screening. Barriers to disease screening include low awareness, lack of access to care and health insurance, and cultural beliefs regarding disease prevention. Our current trial aims to examine community health worker (CHW)-delivered, home-based multi-modality screening for HIV, HCV, CRC, and cervical cancer simultaneously. Design: We are conducting a randomized pragmatic trial among 900 Haitian, Hispanic, and African-American participants from diverse underserved communities in South Florida. People between the ages of 50 and 65 who have not had appropriate HIV, HCV, CRC, and cervical cancer screening per United States Preventive Services Task Force (USPSTF) recommendations are eligible for the study. Participants are recruited by CHWs and complete a structured interview to assess multilevel determinants of disease risk. Participants are then randomized to receive HIV, HCV, CRC, and cervical cancer screening via navigation to care by a CHW (Group 1) or via CHW-delivered home-based screening (Group 2). The primary outcome is completion of screening for each of these diseases within 6 months post-enrollment. Discussion: Our trial is among the first to examine the effectiveness of a CHW-delivered, multimodality, home-based disease-screening approach. If found to be effective, this approach may represent a cost-effective strategy for disease screening within underserved and underscreened minority groups. Trial registration: Clinical Trials.gov # NCT02970136, registered November 21, 2016.
AB - Background: Underserved ethnic minority populations experience significant disparities in HIV, hepatitis C virus (HCV), colorectal cancer (CRC), and cervical cancer incidence and mortality. Much of the excess burden of these diseases among underserved communities is due to lack of preventive care, including screening. Barriers to disease screening include low awareness, lack of access to care and health insurance, and cultural beliefs regarding disease prevention. Our current trial aims to examine community health worker (CHW)-delivered, home-based multi-modality screening for HIV, HCV, CRC, and cervical cancer simultaneously. Design: We are conducting a randomized pragmatic trial among 900 Haitian, Hispanic, and African-American participants from diverse underserved communities in South Florida. People between the ages of 50 and 65 who have not had appropriate HIV, HCV, CRC, and cervical cancer screening per United States Preventive Services Task Force (USPSTF) recommendations are eligible for the study. Participants are recruited by CHWs and complete a structured interview to assess multilevel determinants of disease risk. Participants are then randomized to receive HIV, HCV, CRC, and cervical cancer screening via navigation to care by a CHW (Group 1) or via CHW-delivered home-based screening (Group 2). The primary outcome is completion of screening for each of these diseases within 6 months post-enrollment. Discussion: Our trial is among the first to examine the effectiveness of a CHW-delivered, multimodality, home-based disease-screening approach. If found to be effective, this approach may represent a cost-effective strategy for disease screening within underserved and underscreened minority groups. Trial registration: Clinical Trials.gov # NCT02970136, registered November 21, 2016.
KW - Cervical cancer
KW - Colorectal cancer
KW - HIV
KW - HPV
KW - Haitian
KW - Hepatitis C
KW - Hispanic
KW - Immigrant
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85084170604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084170604&partnerID=8YFLogxK
U2 - 10.1186/s13063-020-4213-7
DO - 10.1186/s13063-020-4213-7
M3 - Article
C2 - 32349789
AN - SCOPUS:85084170604
VL - 21
JO - Trials
JF - Trials
SN - 1745-6215
IS - 1
M1 - 368
ER -